Micronutrients Clinical Trial
Official title:
Longitudinal Zinc Intakes and Exchangeable Zinc Pool Sizes in Breastfed Small for Gestational Age vs Appropriate for Gestational Age Infants in Pakistan
Large-scale zinc supplementation studies have demonstrated highly significant positive
effects on growth, morbidity and mortality in infants who are born small for gestational age
(SGA). This suggests these infants may have higher postnatal requirements compared to
appropriate for gestational age (AGA) infants, possibly due to inadequate zinc intake from
breast milk due either to lower volume or to differences in milk zinc concentrations from
mothers of SGA compared to AGA infants. Alternatively, SGA infants may have lower zinc
stores at birth, which may reflect a greater postnatal requirement for optimal zinc status.
It is thus possible that the zinc requirements of the SGA infant exceed the zinc intake that
can be achieved from exclusive breastfeeding, which is recommended for the first 6 mo of
life. The exchangeable zinc pool (EZP) is defined as the estimate of the total size of the
combined pools of zinc that exchange with zinc in plasma within approximately 2-3 days and
may also differ between SGA and AGA infants.
1. Compare longitudinal zinc intake by measuring milk zinc concentrations and volume of
intake of breast milk between SGA and AGA infants through first 12 mo.
2. Compare post-natal growth rates for SGA and AGA infants through the first 12 mo of life
in relation to zinc intake.
3. Compare size of exchangeable zinc pool (EZP) at birth and at 6 mo of age between SGA
and AGA infants.
Hypotheses:
1. Zinc concentrations in human milk will not be significantly different at any stage of
lactation between mothers of SGA infants and mothers of AGA infants.
2. The volume of breast milk intake relative to body weight will be similar between SGA
and AGA infants, but the total intake will be lower in SGA infants.
3. Linear growth rates, rate of weight gain, and rate of growth in head circumference will
be significantly lower in infants born SGA, and will be positively correlated with
total daily zinc intake.
4. The size of the EZP at birth will be significantly smaller in absolute size and
relative to body weight in infants born SGA compared to AGA
Scientific Background:
Large-scale zinc supplementation studies have demonstrated highly significant positive
effects on growth, morbidity and mortality in infants who are born small for gestational age
(SGA). This suggests these infants may have higher postnatal requirements compared to
appropriate for gestational age (AGA) infants, possibly due to inadequate zinc intake from
breast milk due either to lower volume or to differences in milk zinc concentrations from
mothers of SGA compared to AGA infants. Alternatively, SGA infants may have lower zinc
stores at birth, which may reflect a greater postnatal requirement for optimal zinc status.
It is thus possible that the zinc requirements of the SGA infant exceed the zinc intake that
can be achieved from exclusive breastfeeding, which is recommended for the first 6 mo of
life. Estimated rates of infants born with intrauterine growth retardation, including SGA,
are 25-40% of all births in south Asia (Bhutta - 2004a).
Scientific Scope of the Project (Scientific problems to be addressed with overall and
specific objectives):
The overall objective of this project is to compare zinc intake from human milk and other
fluids and complementary foods in SGA and AGA infants through the first 12 mo of life;
growth for each group will also be monitored. A secondary goal is to compare the size of the
exchangeable zinc pool in SGA and AGA infants at birth and at 6 mo, the period of
recommended exclusive breastfeeding.
Specific Aims:
1. Compare longitudinal zinc intake by measuring milk zinc concentrations and volume of
intake of breast milk between SGA and AGA infants through first 12 mo.
2. Compare post-natal growth rates for SGA and AGA infants through the first 12 mo of life
in relation to zinc intake.
3. Compare size of exchangeable zinc pool (EZP) at birth and at 6 mo of age between SGA
and AGA infants.
Expected Outcomes:
Expected outcomes include longitudinal data from SGA and AGA infants during the first year
of life, including human milk intake, zinc concentrations in human milk, zinc intake from
human milk, estimated intake of non-milk fluids and complementary foods, anthropometric
measurements (length, weight, and head circumference), and size of exchangeable zinc pool;
cross-sectional data on plasma zinc, ferritin and hemoglobin at 6 mo will also be obtained.
These outcomes will all be compared between SGA and AGA infants. Relationships among
variables will also be examined, including relationship of zinc intake and size of EZP to
observed growth outcomes.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00379158 -
Comparison of the Efficacy and Acceptability of Three Types of Micronutrient Supplements in Ghana
|
Phase 4 | |
Completed |
NCT04734938 -
The Effect on Micronutrient Status of a Diet of 100% Huel
|
N/A | |
Active, not recruiting |
NCT06146452 -
Micronutrient Status in Pediatric Palliative Care
|
||
Active, not recruiting |
NCT04564222 -
Sustainable Intervention of Supplementation to Improve Kid's Growth Study
|
N/A | |
Completed |
NCT00872365 -
Effect of Micronutrients and Exercise During Pregnancy on Factors Related With Non-Transmissible Chronic Diseases
|
N/A | |
Completed |
NCT03422809 -
Cyclic Variation in Micronutrient Concentrations and Plasma Volume
|
||
Completed |
NCT04288544 -
"Health Promoting Effects of the Microalgae Phaeodactylum Tricornutum"
|
N/A | |
Completed |
NCT05857345 -
Breastmilk as a Source of Lactocytes
|